[go: up one dir, main page]

CN107686480A - A kind of method for preparing nebivolol epoxides individual isomer - Google Patents

A kind of method for preparing nebivolol epoxides individual isomer Download PDF

Info

Publication number
CN107686480A
CN107686480A CN201610629486.4A CN201610629486A CN107686480A CN 107686480 A CN107686480 A CN 107686480A CN 201610629486 A CN201610629486 A CN 201610629486A CN 107686480 A CN107686480 A CN 107686480A
Authority
CN
China
Prior art keywords
fluoro
chroman
reductase
epoxides
epoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610629486.4A
Other languages
Chinese (zh)
Inventor
杨汉荣
李涛
陶荣盛
王博
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Puyi Chemical Technology Co Ltd
Original Assignee
Shanghai Puyi Chemical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Puyi Chemical Technology Co Ltd filed Critical Shanghai Puyi Chemical Technology Co Ltd
Priority to CN201610629486.4A priority Critical patent/CN107686480A/en
Priority to PCT/CN2017/084869 priority patent/WO2018024017A1/en
Publication of CN107686480A publication Critical patent/CN107686480A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

本发明提供一种制备奈比洛尔环氧化物6‑氟‑2‑(环氧‑2‑基)色满(I)单一异构体的方法。该方法以混旋的2‑氯‑1‑(6‑氟色满‑2‑基)乙‑1‑酮(III)为原料;采用还原酶将其选择性还原,得到带有手性羟基的氯醇(II),然后在碱的存在下生成两个环氧化物的非对映异构体的混合物(R/S)‑(I);再将此混合物通过柱层析的分离制备得到两个对映纯的环氧化物的单一异构体(I)。根据上述方法,如果用R‑还原酶催化还原,则得到的单一异构体为R,R‑(I)和S,R‑(I);如果采用S‑还原酶催化还原,则得到的单一异构体为S,S‑(I)和R,S‑(I)。本发明设计巧妙,合成路线简洁高效,工艺流程简单易行,绿色环保,为工业化制备奈比洛尔环氧化物6‑氟‑2‑(环氧‑2‑基)色满(I)单一异构体提供了新的方法。 The invention provides a method for preparing nebivolol epoxide 6-fluoro-2-(epoxy-2-yl) chroman (I) single isomer. The method uses the mixed 2-chloro-1-(6-fluorochroman-2-yl) ethyl-1-ketone (III) as a raw material; it is selectively reduced by a reductase to obtain a chiral hydroxyl Chlorohydrins (II), then generate a mixture (R/S)-(I) of diastereomers of two epoxides in the presence of a base; then this mixture is prepared by separation of column chromatography to obtain two A single isomer (I) of an enantiopure epoxide. According to the above method, if the reduction is catalyzed by R-reductase, the single isomers obtained are R, R-(I) and S, R-(I); if the reduction is catalyzed by S-reductase, the single isomer obtained is The isomers are S,S‑(I) and R,S‑(I). The present invention is ingenious in design, the synthetic route is simple and efficient, the technological process is simple and easy, and is green and environmentally friendly, and is a single isocyanate (I) for the industrialized preparation of nebivolol epoxide 6-fluoro-2-(epoxy-2-based) chroman (I). Constructs provide a new approach.

Description

一种制备奈比洛尔环氧化物单一异构体的方法A kind of method for preparing single isomer of nebivolol epoxide

技术领域technical field

本发明涉及奈比洛尔合成技术领域,更具体地,涉及6-氟-2-(环氧-2-基)色满的合成技术领域,特别是指一种6-氟-2-(环氧-2-基)色满单一异构体的方法。The present invention relates to the technical field of nebivolol synthesis, more specifically, to the technical field of synthesis of 6-fluoro-2-(epoxy-2-yl) chroman, in particular to a 6-fluoro-2-(cyclo Oxy-2-yl) chroman single isomer method.

背景技术Background technique

盐酸奈比洛尔(Nebivolol)是由美国Johnson&Johnson公司开发,用于治疗原发性高血压的药物,其化学名为α,α’-[亚胺双(亚甲基)双(6-氟-3,4-二氢-2H-1-苯并吡喃-2-甲醇)]盐酸盐,于1997年首次在德国和荷兰上市,是兼有血管扩张作用的心脏选择性β-受体阻滞剂,具有对心脏的保护作用、良好的降压作用、良好耐受性及不良反应少、剂量低疗效好等优点。Nebivolol hydrochloride (Nebivolol) is a drug developed by Johnson & Johnson of the United States for the treatment of essential hypertension. Its chemical name is α, α'-[iminebis(methylene)bis(6-fluoro- 3,4-dihydro-2H-1-benzopyran-2-methanol)] hydrochloride, first listed in Germany and the Netherlands in 1997, is a cardioselective β-receptor blocker with vasodilator effect It has the advantages of protecting the heart, good antihypertensive effect, good tolerance, less adverse reactions, low dose and good curative effect.

奈比洛尔结构式具有四个手性碳原子,共有10个异构体,其中(R,R,R,S)具有很好的受体阻滞性能,而另一构型(S,S,S,R)的异构体虽然没有药物活性但是对于控制NO的释放却有较好的效果。因此,现在的市售药品中,仍然是外消旋体,即是等量的(S,S,S,R)-α,α’-[亚胺双(亚甲基)双(6-氟-3,4-二氢-2H-1-苯并吡喃-2-甲醇)]和(R,R,R,S)-α,α’-[亚胺双(亚甲基)双(6-氟-3,4-二氢-2H-1-苯并吡喃-2-甲醇)]的混合物。The structural formula of Nebivolol has four chiral carbon atoms, and there are 10 isomers in total, among which (R, R, R, S) has good receptor blocking properties, while the other configuration (S, S, Although S, R) isomers have no pharmaceutical activity, they have a better effect on controlling the release of NO. Therefore, in the current commercially available drugs, it is still a racemate, that is, an equivalent amount of (S,S,S,R)-α,α'-[iminebis(methylene)bis(6-fluoro -3,4-dihydro-2H-1-benzopyran-2-methanol)] and (R,R,R,S)-α,α'-[iminobis(methylene)bis(6 -Fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)].

现有技术中已知,合成α,α’-[亚胺双(亚甲基)双(6-氟-3,4-二氢-2H-1-苯并吡喃-2-甲醇)]分子结构对于技术人员是一种挑战。如果采用含有4个异构体的6-氟-2-(环氧-2-基)色满(I) 为原料来合成奈比洛尔,奈比洛尔中4个不对称碳原子产生了16种立体异构体的混合物(在不对称取代的情况下)或10种立体异构体的混合物(在对称取代的情况下)。从奈比洛尔结构中对称的存在显然可以看出,可以产生总共10种立体异构体。It is known in the prior art to synthesize α,α'-[iminobis(methylene)bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)] molecules Structures are a challenge for technicians. If the 6-fluoro-2-(epoxy-2-yl) chroman (I) containing 4 isomers is used to synthesize Nebivolol as a raw material, the 4 asymmetric carbon atoms in Nebivolol produce Mixture of 16 stereoisomers (in case of asymmetric substitution) or mixture of 10 stereoisomers (in case of symmetrical substitution). As is evident from the presence of symmetry in the structure of nebivolol, a total of 10 stereoisomers can be produced.

因此必须先得到6-氟-2-(环氧-2-基)色满(I)的单一异构体,以R,R-(I)和S,R-(I)为原料,反应得到奈比洛尔(R,R,R,S)的异构体,再以S,S-(I)和R,S-(I)为原料,反应得到奈比洛尔(S,S,S,R)的异构体,这样才能避免其它异构体的生成。Therefore, the single isomer of 6-fluoro-2-(epoxy-2-yl) chroman (I) must be obtained earlier, with R, R-(I) and S, R-(I) as raw materials, the reaction is obtained Nebivolol (R, R, R, S) isomers, and then use S, S-(I) and R, S-(I) as raw materials to react to obtain Nebivolol (S, S, S ,R) isomers, so as to avoid the formation of other isomers.

目前合成四个6-氟-2-(环氧-2-基)色满(I)的单一异构体一般是以混旋的6-氟色满-2-羧酸(IV)为原料,经过化学拆分或酶拆分分别得到(S)-6-氟色满-2-羧酸S-(IV)和(R)-6-氟色满-2-羧酸R-(IV),再将它们转化为相应的手性氯酮中间体S-(III)和R-(III)。如果将手性氯酮中间体S-(III)通过两种方法不对称还原或酶还原,分别得到两个手性氯醇中间体S,S-(II)和S,R-(II),再分别关环就得到两个单一构型的6-氟-2-(环氧-2-基)色满S,S-(I)和S,R-(I);如果将手性氯酮中间体R-(III)通过两种方法不对称还原或酶还原,分别得到两个手性氯醇中间体R,S-(II)和R,R-(II),再分别关环就得到另外两个单一构型的6-氟-2-(环氧-2-基)色满R,S-(I)和R,R-(I)。At present, the single isomers of four 6-fluoro-2-(epoxy-2-yl) chroman (I) are generally synthesized with 6-fluorochroman-2-carboxylic acid (IV) as raw material, (S)-6-fluorochroman-2-carboxylic acid S-(IV) and (R)-6-fluorochroman-2-carboxylic acid R-(IV) were obtained respectively through chemical resolution or enzymatic resolution, They are then transformed into the corresponding chiral ketone intermediates S-(III) and R-(III). If the chiral ketone intermediate S-(III) is asymmetrically reduced or enzymatically reduced by two methods, two chiral chlorohydrin intermediates S, S-(II) and S, R-(II) are obtained respectively, Close the ring respectively to obtain two single configurations of 6-fluoro-2-(epoxy-2-yl) chroman S, S-(I) and S, R-(I); if the chiral ketone The intermediate R-(III) is asymmetrically reduced or enzymatically reduced by two methods to obtain two chiral chlorohydrin intermediates R,S-(II) and R,R-(II), and then ring-closing to obtain Two other single-configuration 6-fluoro-2-(epoxy-2-yl)chromans R,S-(I) and R,R-(I).

这种方法虽然得到了四个单一构型的6-氟-2-(环氧-2-基)色满(I),但是存在下面几个问题:Though this method has obtained the 6-fluoro-2-(epoxy-2-base) chroman (I) of four single configurations, there are following problems:

1、拆分6-氟色满-2-羧酸(IV)成本比较高。不论是化学拆分还是酶拆分都比较繁琐,拆分效率不高;而且要同时得到两个构型的异构体,所以单一的(S )-6-氟色满-2-羧酸S-(IV)或(R )-6-氟色满-2-羧酸R-(IV)价格比混旋的6-氟色满-2-羧酸(IV)高很多。1. The cost of splitting 6-fluorochroman-2-carboxylic acid (IV) is relatively high. Both chemical resolution and enzymatic resolution are cumbersome, and the resolution efficiency is not high; and two configurational isomers must be obtained at the same time, so a single ( S )-6-fluorochroman-2-carboxylic acid S -(IV) or ( R )-6-fluorochroman-2-carboxylic acid R-(IV) is much more expensive than vortexed 6-fluorochroman-2-carboxylic acid (IV).

2、6-氟色满-2-羧酸(IV)拆分后,到合成手性氯酮中间体S-(III)和R-(III),必须两个反应并行,而从手性氯酮中间体S-(III)和R-(III)到最后的四个6-氟-2-(环氧-2-基)色满(I)必须四个反应并行,这样操作复杂,不适合工业化生产。2. After the resolution of 6-fluorochroman-2-carboxylic acid (IV), to synthesize chiral ketone intermediates S-(III) and R-(III), two reactions must be performed in parallel, and from chiral chlorine Ketone intermediates S-(III) and R-(III) to the last four 6-fluoro-2-(epoxy-2-yl) chroman (I) must have four reactions in parallel, which is complicated to operate and is not suitable for Industrial production.

发明内容Contents of the invention

针对上述合成6-氟-2-(环氧-2-基)色满(I)四个异构体工艺中存在的问题与不足,本发明提供一种制备奈比洛尔环氧化物6-氟-2-(环氧-2-基)色满(I)单一异构体的方法。该方法设计巧妙,合成路线简洁高效,工艺流程简单易行,绿色环保,为工业化制备奈比洛尔环氧化物6-氟-2-(环氧-2-基)色满(I)单一异构体提供了新的方法。Aiming at the problems and deficiencies in the above-mentioned synthesis of 6-fluoro-2-(epoxy-2-yl) chroman (I) four isomers, the present invention provides a method for preparing nebivolol epoxide 6- Fluoro-2-(epoxy-2-yl)chroman (I) single isomer method. The method is ingeniously designed, the synthetic route is simple and efficient, the process flow is simple and easy, and it is green and environmentally friendly. Constructs provide a new approach.

该方法以混旋的2-氯-1-(6-氟色满-2-基)乙-1-酮(III)为原料;采用还原酶将其选择性还原,得到带有手性羟基的氯醇(II),然后在碱的存在下生成两个环氧化物的非对映异构体的混合物(R/S)-(I);再将此混合物通过柱层析的分离制备得到两个对映纯的环氧化物的单一异构体(I)。The method uses spun 2-chloro-1-(6-fluorochroman-2-yl)ethan-1-one (III) as raw material; it is selectively reduced by reductase to obtain chiral hydroxyl Chlorohydrins (II), and then generate a mixture (R/S)-(I) of diastereoisomers of two epoxides in the presence of a base; then this mixture is prepared by separation by column chromatography to obtain two A single isomer (I) of an enantiopure epoxide.

根据上述方法,所述的还原酶包括R-还原酶和S-还原酶。如果用R-还原酶催化还原,则得到的单一异构体为R,R-(I)和S,R-(I);如果采用S-还原酶催化还原,则得到的单一异构体为S,S-(I)和R,S-(I)。According to the above method, the reductase includes R-reductase and S-reductase. If the reduction is catalyzed by R-reductase, the single isomers obtained are R,R-(I) and S,R-(I); if the reduction is catalyzed by S-reductase, the single isomers obtained are S,S-(I) and R,S-(I).

较佳地,酶还原反应的在C1-4的醇或水与缓冲溶液的混合溶液中,还原酶与辅酶的存在下进行,体系pH为7.0~8.0,反应温度0~30℃。Preferably, the enzyme reduction reaction is carried out in a mixed solution of C 1-4 alcohol or water and buffer solution, in the presence of reductase and coenzyme, the pH of the system is 7.0-8.0, and the reaction temperature is 0-30°C.

较佳地,关环反应以甲苯、丙酮或者C1-4的醇为溶剂,以碱金属氢氧化物为碱,反应温度0~30oC。Preferably, the ring-closing reaction uses toluene, acetone or C 1-4 alcohol as solvent, alkali metal hydroxide as base, and the reaction temperature is 0~30 ° C.

较佳地,柱层析的分离方法中以硅胶为填充物,以二氯甲烷和甲醇的混合溶剂为洗脱剂。Preferably, in the separation method of column chromatography, silica gel is used as a filler, and a mixed solvent of dichloromethane and methanol is used as an eluent.

本发明的有益效果具体在于:The beneficial effects of the present invention are specifically:

1、直接采用混旋的2-氯-1-(6-氟色满-2-基)乙-1-酮(III)为原料,省去了6-氟色满-2-羧酸(IV)的拆分,以及之后分别合成两个手性的2-氯-1-(6-氟色满-2-基)乙-1-酮(III)的工作。降低了原料成本,简化了工艺操作,提高了工业化生产的便捷性。1. Directly adopting 2-chloro-1-(6-fluorochroman-2-yl) ethyl-1-ketone (III) of mixed rotation is a raw material, eliminating the need for 6-fluorochroman-2-carboxylic acid (IV ) resolution, and subsequent work on the synthesis of two chiral 2-chloro-1-(6-fluorochroman-2-yl)ethan-1-ones (III). The cost of raw materials is reduced, the process operation is simplified, and the convenience of industrial production is improved.

2、采用还原酶将混旋的2-氯-1-(6-氟色满-2-基)乙-1-酮(III)选择性还原,得到带有手性羟基的氯醇(II),然后在碱的存在下生成两个环氧化物的非对映异构体的混合物(R/S)-(I);只需要两个并行的反应就可以实现四个6-氟-2-(环氧-2-基)色满(I)的单一异构体的合成。相比原工艺的四个并行反应,工作量减少了一半,效率成倍提高。2. Using reductase to selectively reduce 2-chloro-1-(6-fluorochroman-2-yl)ethan-1-one (III) to obtain chlorohydrin (II) with chiral hydroxyl , then a mixture of diastereoisomers (R/S)-(I) of the two epoxides is generated in the presence of a base; only two parallel reactions are required to achieve four 6-fluoro-2- Synthesis of Single Isomers of (Epoxy-2-yl)chromans (I). Compared with the four parallel reactions of the original process, the workload is reduced by half and the efficiency is doubled.

3、本发明通过柱层析的分离制备得到两个对映纯的环氧化物的单一异构体(I),从而得到四个6-氟-2-(环氧-2-基)色满(I)的单一异构体,这样可以保证每个单一异构体(I)的ee值及de值。避免了原方案中产品的拆分及反应水平的问题。3. The present invention obtains two enantiopure single isomers (I) of epoxides through the separation and preparation of column chromatography, thereby obtaining four 6-fluoro-2-(epoxy-2-yl) chromans The single isomer of (I), can guarantee the ee value and de value of each single isomer (I) like this. The problems of splitting and reaction level of products in the original scheme are avoided.

具体实施方式detailed description

为更好的理解本发明的内容,下面结合具体实施例作进一步说明。应理解,下列具体实施例仅仅用于说明本发明,而不是对本发明的限制。In order to better understand the content of the present invention, the following will be further described in conjunction with specific examples. It should be understood that the following specific examples are only used to illustrate the present invention, rather than limit the present invention.

实施例1:Example 1:

1、(1S )-2-氯-1-(6-氟色满-2-基)乙-1-醇(S-(II))的制备1. Preparation of (1 S )-2-chloro-1-(6-fluorochroman-2-yl)ethan-1-ol (S-(II))

取磷酸二氢钾14.3g,溶于于1080mL蒸馏水中,配置成0.1mol/L的溶液,用2.0 mol/L的氢氧化钠调节pH至7.5,制备缓冲溶液备用。Take 14.3 g of potassium dihydrogen phosphate, dissolve it in 1080 mL of distilled water, and make a 0.1 mol/L solution, adjust the pH to 7.5 with 2.0 mol/L sodium hydroxide, and prepare a buffer solution for later use.

室温下(20oC),向上述缓冲溶液中加入异丙醇720mL,加入2-氯-1-(6-氟色满-2-基)乙-1-酮(III) 45.0g、S-还原酶90.0g及NAD+ 0.18g,再用2.0 mol/L的氢氧化钠调节至7.8,室温反应18小时。检测反应完全后,加入90g硅藻土搅拌均匀,然后过滤,用1000mL乙酸乙酯反复洗涤两次,静置分层,分出第一批次有机相,水相再用1000mL乙酸乙酯萃取两次,合并的有机相用无水硫酸钠干燥、过滤、浓缩得到35.0g浅黄色油状产物(1S )-2-氯-1-(6-氟色满-2-基)乙-1-醇S-(II),收率77.1%。At room temperature (20 o C), add 720 mL of isopropanol to the above buffer solution, add 45.0 g of 2-chloro-1-(6-fluorochroman-2-yl)ethan-1-one (III), S- 90.0 g of reductase and 0.18 g of NAD+ were adjusted to 7.8 with 2.0 mol/L sodium hydroxide, and reacted at room temperature for 18 hours. After the detection reaction is complete, add 90g of diatomaceous earth and stir evenly, then filter, wash twice with 1000mL ethyl acetate, stand and separate the layers, separate the first batch of organic phase, and extract the water phase with 1000mL ethyl acetate for two Once, the combined organic phases were dried over anhydrous sodium sulfate, filtered, and concentrated to obtain 35.0 g of light yellow oily product ( 1S )-2-chloro-1-(6-fluorochroman-2-yl)ethan-1-alcohol S-(II), yield 77.1%.

2、6-氟-2-((R )-环氧-2-基)色满(R-(I))的制备2. Preparation of 6-fluoro-2-(( R )-epoxy-2-yl)chroman (R-(I))

将35.0g (1S )-2-氯-1-(6-氟色满-2-基)乙-1-醇S-(II)溶于180mL甲苯中,体系冷却至0oC以下后,慢慢加入14.6g氢氧化钠固体,然后室温搅拌16小时,TLC显示反应完全。在冰水浴冷却下,滴加11mL醋酸,析出盐,过滤并用150mL乙酸乙酯洗涤盐三次,合并后的有机相分别用400mL水、300mL食盐水各洗涤一次,无水硫酸钠干燥,过滤、旋干、得到30.7g黄色油状物6-氟-2-((R )-环氧-2-基)色满 R-(I),收率98.0%。Dissolve 35.0g (1 S )-2-chloro-1-(6-fluorochroman-2-yl)ethan-1-ol S-(II) in 180mL toluene, cool the system below 0 o C, Slowly add 14.6 g of solid sodium hydroxide, then stir at room temperature for 16 hours, TLC shows that the reaction is complete. Under cooling in an ice-water bath, add 11 mL of acetic acid dropwise to precipitate salt, filter and wash the salt with 150 mL of ethyl acetate three times, wash the combined organic phase with 400 mL of water and 300 mL of saline, dry over anhydrous sodium sulfate, filter, and spin After drying, 30.7 g of yellow oily substance 6-fluoro-2-(( R )-epoxy-2-yl)chroman R-(I) was obtained with a yield of 98.0%.

3、(S )-6-氟-2-((R )-环氧-2-基)色满(S,R-(I))与(R )-6-氟-2-((R )-环氧-2-基)色满(R,R-(I))的制备3. ( S )-6-fluoro-2-(( R )-epoxy-2-yl) chroman (S,R-(I)) and ( R )-6-fluoro-2-(( R ) - Preparation of epoxy-2-yl)chroman (R,R-(I))

取300~400目的硅胶800g装柱,并用二氯甲烷润洗;将上步所得的30.7g黄色油状物6-氟-2-((R )-环氧-2-基)色满 R-(I)溶于50mL二氯甲烷中,湿法上样,然后以二氯甲烷:甲醇=45:1的混合溶液作为流动相洗脱,分别得到13.8g (S )-6-氟-2-((R )-环氧-2-基)色满S,R-(I)和13.6g (R )-6-氟-2-((R )-环氧-2-基)色满R,R-(I),总收率为89.3%,交叉部分未计。Take 800g of silica gel of 300~400 mesh and pack it into a column, and wash it with dichloromethane; 6-fluoro-2-(( R )-epoxy-2-yl)chroman R-( 1) be dissolved in 50mL dichloromethane, wet load sample, then use the mixed solution of dichloromethane:methanol=45:1 as mobile phase elution, obtain 13.8g ( S )-6-fluoro-2-( ( R )-epoxy-2-yl)chroman S,R-(I) and 13.6g ( R )-6-fluoro-2-(( R )-epoxy-2-yl)chroman R,R -(I), the total recovery is 89.3%, and the intersection part is not counted.

实施例2:Example 2:

1、(1R )-2-氯-1-(6-氟色满-2-基)乙-1-醇(R-(II))的制备1. Preparation of (1 R )-2-chloro-1-(6-fluorochroman-2-yl)ethan-1-ol (R-(II))

取磷酸二氢钾15.4g,溶于于1128mL蒸馏水中,配置成0.1mol/L的溶液,用2.0 mol/L的氢氧化钠调节pH至7.0,制备缓冲溶液备用。Take 15.4 g of potassium dihydrogen phosphate, dissolve it in 1128 mL of distilled water, and make a 0.1 mol/L solution, adjust the pH to 7.0 with 2.0 mol/L sodium hydroxide, and prepare a buffer solution for later use.

室温下(20oC),向上述缓冲溶液中加入氯化锌0.22g、甲酸铵94.0g、2-氯-1-(6-氟色满-2-基)乙-1-酮(III) 47.0g、R-还原酶94.0g及NAD+ 0.19g,再用2.0 mol/L的氢氧化钠调节至7.8,室温反应28小时。检测反应完全后,加入94g硅藻土搅拌均匀,然后过滤,用1000mL乙酸乙酯反复洗涤两次,静置分层,分出第一批次有机相,水相再用1000mL乙酸乙酯萃取两次,合并的有机相用无水硫酸钠干燥、过滤、浓缩得到31.5g浅黄色油状产物(1R )-2-氯-1-(6-氟色满-2-基)乙-1-醇R-(II),收率66.4%。At room temperature (20 o C), add 0.22g of zinc chloride, 94.0g of ammonium formate, 2-chloro-1-(6-fluorochroman-2-yl)ethan-1-one (III) to the above buffer solution 47.0 g, 94.0 g of R-reductase and 0.19 g of NAD+, adjusted to 7.8 with 2.0 mol/L sodium hydroxide, and reacted at room temperature for 28 hours. After the detection reaction is complete, add 94g of diatomaceous earth and stir evenly, then filter, wash twice with 1000mL ethyl acetate, stand and separate the layers, separate the first batch of organic phase, and extract the water phase with 1000mL ethyl acetate for two Once, the combined organic phases were dried over anhydrous sodium sulfate, filtered, and concentrated to obtain 31.5 g of light yellow oily product ( 1R )-2-chloro-1-(6-fluorochroman-2-yl)ethan-1-alcohol R-(II), yield 66.4%.

2、6-氟-2-((S )-环氧-2-基)色满(S-(I))的制备2. Preparation of 6-fluoro-2-(( S )-epoxy-2-yl)chroman (S-(I))

将35.0g (1R )-2-氯-1-(6-氟色满-2-基)乙-1-醇S-(II)溶于160mL甲苯中,体系冷却至0oC以下后,慢慢加入24.6g氢氧化钠固体,然后室温搅拌16小时,TLC显示反应完全。在冰水浴冷却下,滴加14mL醋酸,析出盐,过滤并用200mL乙酸乙酯洗涤盐三次,合并后的有机相分别用250mL水、200mL食盐水各洗涤一次,无水硫酸钠干燥,过滤、旋干、得到20.6g黄色油状物6-氟-2-((S )-环氧-2-基)色满 S-(I),收率77.9%。Dissolve 35.0g (1 R )-2-chloro-1-(6-fluorochroman-2-yl)ethan-1-ol S-(II) in 160mL toluene, cool the system below 0 o C, Slowly add 24.6 g of solid sodium hydroxide, then stir at room temperature for 16 hours, TLC shows that the reaction is complete. Under cooling in an ice-water bath, add 14 mL of acetic acid dropwise to precipitate salt, filter and wash the salt with 200 mL of ethyl acetate three times, and wash the combined organic phase with 250 mL of water and 200 mL of saline respectively, dry over anhydrous sodium sulfate, filter, and spin After drying, 20.6g of yellow oily substance 6-fluoro-2-(( S )-epoxy-2-yl)chroman S-(I) was obtained with a yield of 77.9%.

3、(S )-6-氟-2-((S )-环氧-2-基)色满(S,S-(I))与(R )-6-氟-2-((S )-环氧-2-基)色满(R,S-(I))的制备3. ( S )-6-fluoro-2-(( S )-epoxy-2-yl)chroman (S,S-(I)) and ( R )-6-fluoro-2-(( S ) - Preparation of epoxy-2-yl)chroman (R,S-(I))

取300~400目的硅胶600g装柱,并用二氯甲烷润洗;将上步所得的20.6g黄色油状物6-氟-2-((R )-环氧-2-基)色满 R-(I)溶于40mL二氯甲烷中,湿法上样,然后以二氯甲烷:甲醇=40:1的混合溶液作为流动相洗脱,分别得到8.5g (S )-6-氟-2-((S )-环氧-2-基)色满S,S-(I)和8.1g (R )-6-氟-2-((S )-环氧-2-基)色满R,S-(I),总收率为80.4%,交叉部分未计。Take 300~400 mesh silica gel 600g to pack the column, and rinse with dichloromethane; 6-fluoro-2-(( R )-epoxy-2-yl)chroman R-( 1) be dissolved in 40mL dichloromethane, wet load sample, then use the mixed solution of dichloromethane:methanol=40:1 as mobile phase elution, obtain 8.5g ( S )-6-fluoro-2-( ( S )-epoxy-2-yl)chroman S,S-(I) and 8.1g ( R )-6-fluoro-2-(( S )-epoxy-2-yl)chroman R,S -(I), the total recovery is 80.4%, and the intersection part is not counted.

在此说明书中,本发明已参照其特定的实施例作了描述。但是,很显然仍可以作出各种修改和变换而不背离本发明的精神和范围。因此,说明书应被认为是说明性的而非限制性的。In this specification, the invention has been described with reference to specific embodiments thereof. However, it is obvious that various modifications and changes can be made without departing from the spirit and scope of the invention. Accordingly, the specification should be regarded as illustrative rather than restrictive.

Claims (8)

1. one kind prepares the method for the fluoro- 2- of nebivolol epoxides 6- (epoxy -2- bases) chroman (I) individual isomer, the party Method comprises the following steps that:
A) the chloro- 1- of the 2- of DL (6- fluorine chroman -2- bases) second -1- ketone (III) selective reduction is obtained by band using reductase There is the chloropharin (II) of chiral hydroxyl group, then generate the mixture of the diastereoisomer of two epoxides in the presence of base (R/S)-(I);
B) said mixture is prepared to the individual isomer of two pure epoxides of mapping by the separation of column chromatography (I)
2. method according to claim 1, the individual isomer (I) of the epoxides is as shown in following structural formula:
3. method according to claim 1, it is characterised in that described reductase includes R- reductases and S- is reduced Enzyme.
4. method according to claim 1, using R- reductases, the individual isomer being prepared is R, R- (I) and S,R-(I)。
5. method according to claim 1, using S- reductases, the individual isomer being prepared is S, S- (I) and R,S-(I)。
6. method according to claim 1, it is characterised in that enzyme reduction reaction in C1-4Alcohol or water and buffering it is molten In the mixed solution of liquid, reductase in the presence of coenzyme with carrying out, and system pH is 7.0 ~ 8.0, reaction temperature 0 ~ 30oC。
7. method according to claim 1, it is characterised in that ring closure reaction is with toluene, acetone or C1-4Alcohol to be molten Agent, using alkali metal hydroxide as alkali, reaction temperature 0 ~ 30oC。
8. method according to claim 1, it is characterised in that using silica gel as filler in the separation method of column chromatography, Using the mixed solvent of dichloromethane and methanol as eluant, eluent.
CN201610629486.4A 2016-08-04 2016-08-04 A kind of method for preparing nebivolol epoxides individual isomer Pending CN107686480A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201610629486.4A CN107686480A (en) 2016-08-04 2016-08-04 A kind of method for preparing nebivolol epoxides individual isomer
PCT/CN2017/084869 WO2018024017A1 (en) 2016-08-04 2017-05-18 Preparation method for 6-fluoro-2-(epoxy-2-yl)chroman

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610629486.4A CN107686480A (en) 2016-08-04 2016-08-04 A kind of method for preparing nebivolol epoxides individual isomer

Publications (1)

Publication Number Publication Date
CN107686480A true CN107686480A (en) 2018-02-13

Family

ID=61073225

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610629486.4A Pending CN107686480A (en) 2016-08-04 2016-08-04 A kind of method for preparing nebivolol epoxides individual isomer

Country Status (2)

Country Link
CN (1) CN107686480A (en)
WO (1) WO2018024017A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102127061A (en) * 2010-01-15 2011-07-20 浙江华海药业股份有限公司 Improvement method for preparing 6-fluorin-3,4-dihydro-2H-1-benzopyranyl-2-epoxy ethane
CN103228640A (en) * 2010-11-30 2013-07-31 马纳里尼国际运转卢森堡股份公司 Process for the preparation of nebivolol
CN104016954A (en) * 2014-06-06 2014-09-03 常州市第四制药厂有限公司 Method for preparing and purifying nebivolol intermediate
CN105503842A (en) * 2015-12-24 2016-04-20 广安凯特医药化工有限公司 Method for preparing nebivolol hydrochloride epoxy intermediate 6-fluoro-2-epoxy ethyl chroman

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102127061A (en) * 2010-01-15 2011-07-20 浙江华海药业股份有限公司 Improvement method for preparing 6-fluorin-3,4-dihydro-2H-1-benzopyranyl-2-epoxy ethane
CN103228640A (en) * 2010-11-30 2013-07-31 马纳里尼国际运转卢森堡股份公司 Process for the preparation of nebivolol
CN104016954A (en) * 2014-06-06 2014-09-03 常州市第四制药厂有限公司 Method for preparing and purifying nebivolol intermediate
CN105503842A (en) * 2015-12-24 2016-04-20 广安凯特医药化工有限公司 Method for preparing nebivolol hydrochloride epoxy intermediate 6-fluoro-2-epoxy ethyl chroman

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
舒楠,等: "醛酮还原酶的研究进展", 《药物生物技术》 *

Also Published As

Publication number Publication date
WO2018024017A1 (en) 2018-02-08

Similar Documents

Publication Publication Date Title
EP2528905B1 (en) Process for the preparation of nebivolol
CN107311875A (en) The synthetic method of aramine
JP7039643B2 (en) New method for synthesizing catechin
US10913756B2 (en) Phosphoramidate compound and preparation method and crystal thereof
CN113508120B (en) Method for preparing cannabidiol
NO328561B1 (en) Process for the preparation of escitalopram, and intermediates thereof.
ES2553266T3 (en) Nebivolol preparation process
WO2006106531A1 (en) Process for the preparation of escitalopram or its acid addition salts
JP5502849B2 (en) Nebivolol preparation process
CN107686480A (en) A kind of method for preparing nebivolol epoxides individual isomer
CN107108607B (en) Process for preparing praziquantel
CN109071551A (en) A kind of preparation method for the pyran derivate that trifluoromethyl replaces
CN108239091A (en) The fractionation of 1- cyclohexyl -2- (5H- imidazoles [5,1-a] iso-indoles) ethyl -1- ketone
TW200808754A (en) Benzodioxane and benzodioxolane derivatives and uses thereof
CN104829571B (en) Escitalopram oxalate related substances and preparation method thereof
CN104058990A (en) Separation analysis method of aliskiren and salts thereof
KR20130107698A (en) A PROCESS FOR PREPARING HIGH PURITY OF (s)-METOPROLOL
CN101883486A (en) Method for preparing R-gossypol L-phenylalaninol dienamine
CN107382929A (en) Application of the enzyme technology in the synthesis of Ao Gelieting intermediates
CN106349112A (en) Preparation method of methocarbamol beta isomer
CN109942442A (en) A kind of preparation method of dapoxetine hydrochloride related substance I
CN107698533A (en) A kind of method for preparing Linezolid
Gur’eva et al. Chiral imines and amines based on 2-hydroxypinan-3-one
CN108084049B (en) Preparation method of posaconazole intermediate
CN106928139B (en) A kind of shellfish reaches the synthetic method of quinoline impurity

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180213